Trademark: 79321010
Word

Status
Registered
Status Code
700
Status Date
Tuesday, April 4, 2023
Serial Number
79321010
Registration Number
7014557
Registration Date
Tuesday, April 4, 2023
Mark Type
2000
Filing Date
Monday, August 2, 2021
Published for Opposition
Tuesday, January 17, 2023

Trademark Owner History
Adam Andrzej Plich - Original Registrant

Classifications
5 Pharmaceutical products, namely, pharmaceutical preparations for the treatment of viral, infectious, parasitic, metabolic, endocrine, nutritional, musculoskeletal, cardiovascular, cardiopulmonary, circulatory system diseases, genitourinary, pregnancy, childbirth, puerperium and perinatal period disorders, developmental anomalies, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, otolaryngological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, behavioural, neurodevelopmental, sleep-wake and immune system related diseases and disorders; medical and veterinary pharmaceutical preparations for the treatment of viral, infectious, parasitic, metabolic, endocrine, nutritional, musculoskeletal, cardiovascular, cardiopulmonary, circulatory system diseases, genitourinary, pregnancy, childbirth, puerperium and perinatal period disorders, developmental anomalies, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, otolaryngological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, behavioural, neurodevelopmental, sleep-wake and immune system related diseases and disorders; biotechnological preparations for medical, pharmaceutical and veterinary purposes, namely, biotechnological preparations for the treatment of viral, infectious, parasitic, metabolic, endocrine, nutritional, musculoskeletal, cardiovascular, cardiopulmonary, circulatory system diseases, genitourinary, pregnancy, childbirth, puerperium and perinatal period disorders, developmental anomalies, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, otolaryngological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, behavioural, neurodevelopmental, sleep-wake and immune system related diseases and disorders; biological preparations for medical, pharmaceutical and veterinary purposes, namely, biological preparations for the treatment of viral, infectious, parasitic, metabolic, endocrine, nutritional, musculoskeletal, cardiovascular, cardiopulmonary, circulatory system diseases, genitourinary, pregnancy, childbirth, puerperium and perinatal period disorders, developmental anomalies, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, otolaryngological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, behavioural, neurodevelopmental, sleep-wake and immune system related diseases and disorders; biological implants, namely, a vital processed human or animal connective tissue; chemical preparations for medical, pharmaceutical and veterinary purposes, namely, preparations for the treatment of viral, infectious, parasitic, metabolic, endocrine, nutritional, musculoskeletal, cardiovascular, cardiopulmonary, circulatory system diseases, genitourinary, pregnancy, childbirth, puerperium and perinatal period disorders, developmental anomalies, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, otolaryngological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, behavioural, neurodevelopmental, sleep-wake and immune system related diseases and disorders; chemico pharmaceutical preparations, namely, preparations for pharmaceutical or medical purposes for the treatment of viral, infectious, parasitic, metabolic, endocrine, nutritional, musculoskeletal, cardiovascular, cardiopulmonary, circulatory system diseases, genitourinary, pregnancy, childbirth, puerperium and perinatal period disorders, developmental anomalies, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, otolaryngological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, behavioural, neurodevelopmental, sleep-wake and immune system related diseases and disorders; sanitary preparations for medical purposes; dietetic foods and substances adapted for medical or veterinary use, namely, dietetic preparations adapted for medical purposes, dietetic foods adapted for medical use, dietetic sugar substitutes for medical use; dietary supplements for human beings and animals; medical plasters, materials for dressings, namely, sterilized dressing, bandages for dressings, wadding for dressings; disinfectants; preparations for destroying vermin
The mark consists of a design of a shield, outlined in a green line with a green solid triangle on each side of the upper portion of the shield, with a green polygon inside at the top, with two green connecting triangles at each side underneath. The color white represents background, outlining, shading and/or transparent areas and is not part of the mark.
Green - the outline of the drawing, surface of some polygons.
The color(s) green is/are claimed as a feature of the mark.

Trademark Events
Aug 14, 2023
Final Decision Transaction Processed By Ib
Jul 21, 2023
Final Disposition Notice Sent To Ib
Jul 21, 2023
Final Disposition Processed
Jul 4, 2023
Final Disposition Notice Created, To Be Sent To Ib
Apr 4, 2023
Notice Of Registration Confirmation Emailed
Apr 4, 2023
Registered-Principal Register
Mar 20, 2023
Notification Of Possible Opposition - Processed By Ib
Mar 1, 2023
Notification Of Possible Opposition Sent To Ib
Mar 1, 2023
Notification Of Possible Opposition Created, To Be Sent To Ib
Jan 26, 2023
Notification Processed By Ib
Jan 17, 2023
Official Gazette Publication Confirmation E-Mailed
Jan 17, 2023
Published For Opposition
Jan 4, 2023
Notification Of Possible Opposition Sent To Ib
Jan 4, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Dec 28, 2022
Notification Of Notice Of Publication E-Mailed
Dec 13, 2022
Approved For Pub - Principal Register
Dec 12, 2022
Examiner's Amendment Entered
Dec 12, 2022
Notification Of Examiners Amendment E-Mailed
Dec 12, 2022
Examiners Amendment E-Mailed
Dec 12, 2022
Examiners Amendment -Written
Dec 1, 2022
Teas/Email Correspondence Entered
Dec 1, 2022
Correspondence Received In Law Office
Dec 1, 2022
Teas Response To Office Action Received
Jul 5, 2022
Refusal Processed By Ib
Jun 10, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Jun 9, 2022
Refusal Processed By Mpu
May 7, 2022
Non-Final Action (Ib Refusal) Prepared For Review
May 6, 2022
Non-Final Action Written
Apr 29, 2022
Assigned To Examiner
Oct 5, 2021
Application Filing Receipt Mailed
Sep 29, 2021
New Application Office Supplied Data Entered
Sep 23, 2021
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24